Hypertrophic heart phenotype is characterized by an abnormal left ventricular (LV) thickening. A hypertrophic phenotype can develop as adaptive response in many different conditions such as aortic stenosis, hypertension, athletic training, infiltrative heart muscle diseases, storage disorders and metabolic disorders. Hypertrophic cardiomyopathy (HCM) is the most frequent primary cardiomyopathy (CMP) and a genetical cause of cardiac hypertrophy. It requires the exclusion of any other cause of LV hypertrophy. Cardiac magnetic resonance (CMR) is a comprehensive imaging technique that allows a detailed evaluation of myocardial diseases. It provides reproducible measurements and myocardial tissue characterization. In clinical practice CMR is increasingly used to confirm the presence of ventricular hypertrophy, to detect the underlying cause of the phenotype and more recently as an efficient prognostic tool. This article aims to provide a detailed overview of the applications of CMR in the setting of hypertrophic heart phenotype and its role in the diagnostic workflow of such condition.

Cardiac magnetic resonance of hypertrophic heart phenotype: A review

Faletti, Riccardo;Gaetani, Clara;Bozzo, Elena;Biondo, Andrea;Carisio, Andrea;Menchini, Francesca;Miccolis, Maria;Papa, Francesco Pio;Trovato, Martina;Fonio, Paolo;Gatti, Marco
2023-01-01

Abstract

Hypertrophic heart phenotype is characterized by an abnormal left ventricular (LV) thickening. A hypertrophic phenotype can develop as adaptive response in many different conditions such as aortic stenosis, hypertension, athletic training, infiltrative heart muscle diseases, storage disorders and metabolic disorders. Hypertrophic cardiomyopathy (HCM) is the most frequent primary cardiomyopathy (CMP) and a genetical cause of cardiac hypertrophy. It requires the exclusion of any other cause of LV hypertrophy. Cardiac magnetic resonance (CMR) is a comprehensive imaging technique that allows a detailed evaluation of myocardial diseases. It provides reproducible measurements and myocardial tissue characterization. In clinical practice CMR is increasingly used to confirm the presence of ventricular hypertrophy, to detect the underlying cause of the phenotype and more recently as an efficient prognostic tool. This article aims to provide a detailed overview of the applications of CMR in the setting of hypertrophic heart phenotype and its role in the diagnostic workflow of such condition.
2023
Inglese
Esperti anonimi
9
6
e17336
0
16
Amyloidosis; Anderson-fabry disease; CMR; Cardiac hypertrophy; HCM; Iron overload; Sarcoidosis
no
1 – prodotto con file in versione Open Access (allegherò il file al passo 6 - Carica)
12
03-CONTRIBUTO IN RIVISTA::03B-Review in Rivista / Rassegna della Lett. in Riv. / Nota Critica
open
262
info:eu-repo/semantics/article
Tore, Davide; Faletti, Riccardo; Gaetani, Clara; Bozzo, Elena; Biondo, Andrea; Carisio, Andrea; Menchini, Francesca; Miccolis, Maria; Papa, Francesco ...espandi
File in questo prodotto:
File Dimensione Formato  
Tore2023_Cardiac magnetic resonance of hypertrophic heart phenotype: A review.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 7.08 MB
Formato Adobe PDF
7.08 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1942130
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact